June 2024 Br J Cardiol 2024;31:68–72 doi:10.5837/bjc.2024.025
Benjamin Dowsing, C Fielder Camm, Hibba Kurdi
Introduction This four-part editorial series aims to guide UK cardiology trainees and cardiovascular professionals through the key stages of early career research. Part 1 examined the role a period of research may play in a cardiologist’s career development,1 and part 2 explored how to identify the different research opportunities available.2 In this next part, we focus on the practical aspects of beginning your research journey; it explores the role of funders, sponsors, and regulatory bodies, as well as attempting to demystify the terminology associated with research logistics (online glossary). Glossary. Common terms in the research ap
September 2018 doi:10.5837/bjc.2018.s11
BJC Staff
Importance of UK collaboration with the EU The partnerships between the UK and other EU Member States significantly increase the impact and influence of the EU’s science and research activity. When collaborating with the UK, the share of EU co-authored publications in the top 10% of highly cited publications in medical and health research is higher.2 The UK is also a top five collaboration partner for each of the other 27 Member States,3 and contributed almost 20% of the total research work carried out within EU health programmes between 2007–2016.2 European collaboration is particularly important in some fields – stratified medicine a
September 2018 doi:10.5837/bjc.2018.s11
This article is based on a presentation made by Dr Mark Toms and Dr Tom Thuren
This investment in research also benefits the UK economy providing employment, trade, and addressing shortfalls in STEM skills (Science, Technology, Engineering, and Mathematics). In addition to giving patients faster access to treatments, getting efficacious and safe medicines registered more efficiently enables the trial sponsor to gain reimbursement for those medications sooner. Evolving bio-pharmaceutical model Medical research changed dramatically with the discovery of the structure of DNA and the subsequent understanding of genetic code, with DNA sequencing and amplification. This has led to medicines becoming increasingly personalised
September 2018 doi:10.5837/bjc.2018.s11
This article is based on a presentation made by Professor John Pepper
The Institute of Cardiovascular Medicine and Science (ICMS) is a world-class body set up to improve outcomes in cardiovascular medicine drawing on the combined clinical expertise of its founding partners: Royal Brompton and Hare eld NHS Foundation Trust (RB&HFT) and Liverpool Heart and Chest Hospital NHS Foundation Trust (LHCH). Founded in 2011 as a joint venture, it was formed as a company limited by guarantee and registered at Companies’ House. Initial investment by each Trust of £50,000 was followed up by further investment in 2015 of £50,000 by each Trust. It is supported by its academic partner, Imperial College London. The I
September 2018 doi:10.5837/bjc.2018.s11
This article is based on a presentation made by Professor Martin Gibson
The innovative and trustworthy use of routinely collected healthcare data has enabled a UK company, NorthWest Ehealth, experts in the use of this technology, to become the only organisation in the world to have evaluated the safety and effectiveness of a pre-license medicine in a real-world setting. Its technology can support the whole clinical trial lifecycle and enable more effective feasibility, economic modelling, recruitment, real-time safety monitoring and data analytics. ‘The use of electronic healthcare records for clinical research is helping change the clinical trial landscape’ The EHR and future of clinical trials The use of e
September 2018 doi:10.5837/bjc.2018.s11
This article is based on a presentation made by Sarah Fallon
The NIHR represents the most integrated health research system in the world and is the research arm of the National Health Service (NHS). Its national network enables access to experts and trained staff in all therapeutic specialties across the country and opens up collaboration possibilities between groups with similar research interests. The NHS: an incredible research resource the largest publicly funded health service in the world looks after one million people every 36 hours all inclusive, free to access, it provides a representative population, with the NHS number a unique identifier for patients so they can be followed through the
September 2005 Br J Cardiol 2005;12:372-8
Hugh JN Bethell, Julia Evans, Sheila Malone, Sally C Turner
No content available
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits